Literature DB >> 11684676

Serine-arginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing.

A E Cowper1, J F Cáceres, A Mayeda, G R Screaton.   

Abstract

We have characterized two RNA-binding proteins, of apparent molecular masses of approximately 40 and 35 kDa, which possess a single N-terminal RNA-recognition motif (RRM) followed by a C-terminal domain rich in serine-arginine dipeptides. Their primary structures resemble the single-RRM serine-arginine (SR) protein, SC35; however their functional effects are quite distinctive. The 40-kDa protein cannot complement SR protein-deficient HeLa cell S100 extract and showed a dominant negative effect in vitro against the authentic SR proteins, SF2/ASF and SC35. Interestingly, the 40- and 35-kDa proteins antagonize SR proteins and activate the most distal alternative 5' splice site of adenovirus E1A pre-mRNA in vivo, an activity that is similar to that characterized previously for the heterogeneous nuclear ribonucleoprotein particles A/B group of proteins. A series of recombinant chimeric proteins consisting of domains from these proteins and SC35 in various combinations showed that the RRM, but not the C-terminal domain rich in serine-arginine dipeptides, has a dominant role in this activity. Because of the similarity to SR proteins we have named these proteins SRrp40 and SRrp35, respectively, for SR-repressor proteins of approximately 40 and approximately 35 kDa. Both factors show tissue- and cell type-specific patterns of expression. We propose that these two proteins are SR protein-like alternative splicing regulators that antagonize authentic SR proteins in the modulation of alternative 5' splice site choice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684676     DOI: 10.1074/jbc.M103967200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins.

Authors:  Daron C Barnard; Jun Li; Rui Peng; James G Patton
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

2.  A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells.

Authors:  Md Talat Nasim; H M Chowdhury; I C Eperon
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.

Authors:  Shirley R Bruce; R W Cameron Dingle; Martha L Peterson
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

4.  A single ancient origin for prototypical serine/arginine-rich splicing factors.

Authors:  Sophie Califice; Denis Baurain; Marc Hanikenne; Patrick Motte
Journal:  Plant Physiol       Date:  2011-12-12       Impact factor: 8.340

Review 5.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

6.  SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.

Authors:  Jane Y Wu; Amar Kar; David Kuo; Bing Yu; Necat Havlioglu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

7.  Utilizing Yeast Surface Human Proteome Display Libraries to Identify Small Molecule-Protein Interactions.

Authors:  Scott Bidlingmaier; Bin Liu
Journal:  Methods Mol Biol       Date:  2015

Review 8.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

9.  Regulation of alternative splicing by SRrp86 and its interacting proteins.

Authors:  Jun Li; Ian C Hawkins; Christopher D Harvey; Jennifer L Jennings; Andrew J Link; James G Patton
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 10.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.